ŞAHİN, E. Ö. Et Al. 2019. 3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa. ESGCT 27th Annual Congress in collaboration with SETGyc , (Barcelona, Spain), 1.

ŞAHİN, E. Ö., ERENDOR, F., BİŞGİN, A., CEYLANER, S., & ŞANLIOĞLU, S., (2019). 3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa . ESGCT 27th Annual Congress in collaboration with SETGyc (pp.1). Barcelona, Spain

ŞAHİN, ELİF Et Al. "3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa," ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, Spain, 2019

ŞAHİN, ELİF Ö. Et Al. "3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa." ESGCT 27th Annual Congress in collaboration with SETGyc , Barcelona, Spain, pp.1, 2019

ŞAHİN, E. Ö. Et Al. (2019) . "3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa." ESGCT 27th Annual Congress in collaboration with SETGyc , Barcelona, Spain, p.1.

@conferencepaper{conferencepaper, author={ELİF ÖZGECAN ŞAHİN Et Al. }, title={3- New gene therapy modalities targeting oxidative stress and microglial activation are needed for effective treatment of retinitis pigmentosa}, congress name={ESGCT 27th Annual Congress in collaboration with SETGyc}, city={Barcelona}, country={Spain}, year={2019}, pages={1} }